Retraction notice to "Extending clomiphene treatment in clomiphene-resistant women with PCOS: a randomized controlled trial" (RBMO 16/6 (2008) 825-829(10.1016/S1472-6483(10)60148-4));Extending clomiphene treatment in clomiphene-resistant women with PCOS: A randomized controlled trial

Reproductive BioMedicine Online

Volumn 16, Issue 6, 2008, Pages 825-829

  Badawy, Ahmed M ^a   Allam, Abdelfattah ^a   Abulatta, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Extended clomiphene citrate; PCOS

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; CLOMIFENE CITRATE; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE;

ABSENCE OF SIDE EFFECTS; ADULT; ANOVULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; TWIN PREGNANCY;

EID: 45749092599     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2023.103374     Document Type: Erratum

References (20)

1. Badawy A, El Nashar A, El Totongy M 2006 Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertility and Sterility 86, 647-670.
2. Branigan E, Estes A 2003 A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. American Journal of Obstetrics and Gynecology 188, 1424-1428.
3. Elnashar A, Abdelmageed E, Fayed M, Sharaf M 2006 Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study Human Reproduction 21, 1805-1808.
4. Farhi J, Soule S, Jacobs HS 1995 Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertility and Sterility 64, 930-935.
5. Franks S, Adams J, Mason H, Polson D 1985 Ovulatory disorders in women with polycystic ovary syndrome. Clinical Obstetrics and Gynecology 12, 605-632.
6. Guzick D 1998 Polycystic ovary syndrome. Symptomatology, pathophysiology and epidemiology. American Journal of Obstetrics and Gynecology 179, 89-93.
7. Homburg R 2005 Clomiphene citrate - end of an era? a mini-review. Human Reproduction 20, 2043-2051.
8. Homburg R, Armar NA, Eshel A et al. 1988 Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 297, 1024-1026.
9. Imani B, Eijkemans MJ, te Velde ER et al. 2002 A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertility and Sterility 77, 91-97.
10. Imani B, Eijkemans MJ, te Velde ER et al. 1998 Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal of Clinical Endocrinology and Metabolism 83, 2361-2365.
11. Kashyap S, Wells GA, Rosenwaks Z 2004 Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Human Reproduction 19, 2474-2483.
12. Kovacs G, Wood C 2001 The current status of polycystic ovary syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology 41, 65-68.
13. Lord JM, Flight IH, Norman RJ 2003 Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews CD003053.
14. Mitwally M, Casper R 2001 Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertility and Sterility 75, 305-309.
15. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25.
16. Shoham Z, Borenstein R, Lunenfeld B, Pariente C 1990 Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clinical Endocrinology 33, 271-278.
17. Welt CK, Adams JM, Sluss PM, Hall JE 1999 Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. Journal of Clinical Endocrinology and Metabolism 84, 2163-2169.
18. Welt CK, Martin KA, Taylor AE et al. 1997 Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. Journal of Clinical Endocrinology and Metabolism 82, 2645-2652.
19. World Health Organisation 1999 WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interactions 4th edition Cambridge University Press, Cambridge, UK.
20. Youssef H, Attallah M 2007 Unilateral ovarian drilling in polycystic ovarian syndrome: a prospective randomized study. Reproductive BioMedicine Online 15, 457-462.